Finance

Lists
214390:KRX
Kyongbo Pharmaceutical Co Ltd
5 350,00 KRW
+1,90%
(+100,00) 1D
19 ოქტ, 15:30:30 GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 214390...
Open
5 250 KRW
High
5 420 KRW
Low
5 250 KRW
Mkt. cap
127,90 მლრ.
Avg. vol.
24,96 ათ.
Volume
15,49 ათ.
Dividend
0,93%
Quarterly dividend
12 KRW
Ex-dividend date
29 დეკ. 2025
P/E ratio
25,41
52-wk high
9 300 KRW
52-wk low
4 700 KRW
EPS
211 KRW
Shares outstanding
23,91 მლნ.
No. of employees
588
Open
5 250 KRW
High
5 420 KRW
Low
5 250 KRW
Mkt. cap
127,90 მლრ.
Avg. vol.
24,96 ათ.
Volume
15,49 ათ.
Dividend
0,93%
Quarterly dividend
12 KRW
Ex-dividend date
29 დეკ. 2025
P/E ratio
25,41
52-wk high
9 300 KRW
52-wk low
4 700 KRW
EPS
211 KRW
Shares outstanding
23,91 მლნ.
No. of employees
588
News stories
From web sources and news partners
About Kyongbo Pharmaceutical Co Ltd
CEOკიმ ტაე-იუნგ
Employees588
Founded31 მარ. 1987
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
66,99 მლრდ.
71,22 მლრდ.
66,13 მლრდ.
75,22 მლრდ.
Cost of goods sold
42,39 მლრდ.
44,46 მლრდ.
38,69 მლრდ.
46,54 მლრდ.
Cost of revenue
42,39 მლრდ.
44,46 მლრდ.
38,69 მლრდ.
46,54 მლრდ.
Research and development expenses
4,46 მლრდ.
4,50 მლრდ.
4,92 მლრდ.
4,99 მლრდ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
18,88 მლრდ.
20,67 მლრდ.
20,97 მლრდ.
21,99 მლრდ.
Operating expense
24,12 მლრდ.
26,24 მლრდ.
26,73 მლრდ.
27,75 მლრდ.
Total operating expenses
66,51 მლრდ.
70,70 მლრდ.
65,41 მლრდ.
74,29 მლრდ.
Operating income
474,48 მლნ.
515,50 მლნ.
712,77 მლნ.
930,33 მლნ.
Other non operating income
-1,10 მლრდ.
2,51 მლრდ.
-1,44 მლრდ.
3,36 მლრდ.
EBT including unusual items
3,44 მლრდ.
-995,05 მლნ.
-741,91 მლნ.
4,27 მლრდ.
EBT excluding unusual items
3,44 მლრდ.
-857,95 მლნ.
-741,91 მლნ.
4,27 მლრდ.
Income tax expense
412,26 მლნ.
-562,40 მლნ.
-212,24 მლნ.
1,29 მლრდ.
Effective tax rate
11,97%
56,52%
28,61%
30,33%
Other operating expenses
194,62 მლნ.
276,72 მლნ.
190,08 მლნ.
187,64 მლნ.
Net income
3,03 მლრდ.
-432,65 მლნ.
-529,67 მლნ.
2,97 მლრდ.
Net profit margin
4,53%
-0,61%
-0,80%
3,95%
Earnings per share
-
-
-
-
Interest and investment income
-
41,30 მლნ.
-
-
Interest expense
-
-4,29 მლრდ.
-
-
Net interest expenses
-
-4,25 მლრდ.
-
-
Depreciation and amortization charges
377,69 მლნ.
385,22 მლნ.
323,46 მლნ.
327,67 მლნ.
EBITDA
3,86 მლრდ.
3,95 მლრდ.
4,29 მლრდ.
4,64 მლრდ.
Gain or loss from assets sale
-6,40 მლნ.
10,00 ათ.
-5,48 მლნ.
13,90 მლნ.
AI content may include mistakes. Learn more
Google აპები